Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 1.000 | |
| 4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.569 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.561 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.542 | |
| 2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.516 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.514 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.507 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.507 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.505 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.505 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.504 | |
| 3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.495 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.491 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.491 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.490 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.488 | |
| 3c4z | ADP | Rhodopsin kinase | / | 0.485 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.483 | |
| 2jko | BIJ | Focal adhesion kinase 1 | 2.7.10.2 | 0.480 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.480 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.480 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.479 | |
| 4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.478 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.477 | |
| 3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.474 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.470 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.470 | |
| 3qc9 | ADP | Rhodopsin kinase | / | 0.470 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.470 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.470 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.463 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.462 | |
| 4l9i | 8PR | Rhodopsin kinase | / | 0.462 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.461 | |
| 4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.459 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.458 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.458 | |
| 4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.458 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.458 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.458 | |
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.457 | |
| 3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.457 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.456 | |
| 3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.456 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
| 3bqr | 4RB | Death-associated protein kinase 3 | / | 0.454 | |
| 4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.454 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
| 3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.453 | |
| 5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.453 | |
| 4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 4i4e | 1BQ | Focal adhesion kinase 1 | 2.7.10.2 | 0.451 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.451 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.450 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.450 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.450 | |
| 4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.450 | |
| 4brx | KGW | Focal adhesion kinase 1 | 2.7.10.2 | 0.450 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.450 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.449 | |
| 4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.449 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.448 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
| 3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.448 | |
| 4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
| 4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.448 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.447 | |
| 1jkk | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
| 2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.447 | |
| 2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.446 | |
| 4ct2 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.446 | |
| 1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.445 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.445 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.445 | |
| 1jqh | ANP | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.444 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.444 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.444 | |
| 2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.443 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
| 3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.443 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
| 1mp8 | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.441 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.441 | |
| 4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.441 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.441 | |
| 4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
| 5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.441 | |
| 1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.440 | |
| 2w4j | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.440 | |
| 3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.440 | |
| 3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 |